FIELD OF THE INVENTION:
The present invention relates to a pesticidal active mixture which comprises at least one pesticidally
5 active thietanyloxy compound of formula (1), oxides or a salt thereof as a component (1) and at least
one insecticidally active compound (II) or at least one fungicidally active compound (III) as a
component (2). Further, the present invention relates to a method for controlling invertebrate pests
and/or phytopathogenic fungi of plants, to the use of the mixture for seed treatment, to a method for
protecting seeds and to the corresponding treated seeds.
10 BACKGROUND OF THE INVENTION:
One of the problem/needs in controlling pests is to reduce the application rates of the pesticide in
order to reduce or avoid environmental or toxicological effects while, at the same time, achieving
effective pest control. The need to have pest control agents effective against a broad spectrum of pests
is another challenge.
15 There also exists the need for pest control agents that provide quick action as well as long lasting
activity in order to reduce the number of applications.
Another difficulty in relation to the use of solo pesticides 1s that the repeated and exclusive
application in most of the cases leads to natural or adapted resistance against the pesticidally active
compound. Therefore, there is a need for pest control means that help prevent or overcome resistance.
20 Furthermore, there is a desire for pesticidal active mixtures which, when applied, improve plant
health, increase vitality of plant propagation or enhance yield.
Therefore, obtaining a pesticidal active mixture that demonstrates a higher controlling effect with
reduced environmental or toxicological effects in addition to addressing one or more of the above
discussed problems, is highly desirable.
25 W02019150220 discloses a compound of the following formula
wherein,
W1 and W2 represent 0; B1 and B2 represent C;
1
wo 2022/009058
D is fragment D4
..{_ eN
'~ N~R'
Rs
04
wherein, x is hydrogen, fluorine or chlorine;
Z1 represents 0; E represents thietanyl group;
5 R1 represents NR10R11 wherein R10 is hydrogen or methyl;
R3 represents cyano, fluorine, chlorine, bromine, methyl and trifluoromethyl;
R4 represents hydrogen;
R5 represents hydrogen, halogen;
10 and m represents an integer 2.
PCT/IB2021/055992
Surprisingly, it has been found that the pesticidal active mixture according to the present invention not
only brings about the additive enhancement of the spectrum of action with respect to the
pest/phytopathogen to be controlled, that was in principle to be expected, but also achieves a
synergistic effect. The synergistic effect of the pesticidal active mixture of the present invention helps
15 to reduce the application rate of component (1) selected from thietanyloxy compounds of formula (I)
and component (2) which is at least one additional insecticidally active compound (II) or at least one
fungicidally active compound (III) by maintaining the level of efficacy even if the two individual
compounds alone have become less or close to ineffective at such low application rates. Also it allows
a substantial broadening of the spectrum of phytopathogens that can be controlled by, at the same
20 time, increasing the safety in use.
SUMMARY OF THE INVENTION:
Accordingly, the present invention provides a pesticidal active mixture comprising acomponent (1) as
thietanyloxy compound of formula (1), oxides or a salt thereof,
2
wo 2022/009058 PCT/IB2021/055992
Formula (I)
and a component (2) is at least one insecticidally active compound (II) selected from the group
5 consisting of:
(II-1) Acetylcholinesterase (AChE) inhibitors,
(II-2) GABA-gated chloride channel blockers,
(II-3) Sodium channel modulators,
(II-4) Nicotinic acetylcholine receptor (nAChR) competitive modulators,
10 (II-5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators- Site I,
(II-6) Glutamate-gated chloride channel (GluCl) allosteric modulators,
(II-7) Juvenile hormone mimics,
(II-8) Miscellaneous non-specific (multi-site) inhibitors,
(II-9) Chordotonal organ TRPV channel modulators,
15 (II -10) Mite growth inhibitors affecting CHS 1,
(II -11) Microbial disruptors of insect midgut membranes,
(II-12) Inhibitors of mitochondrial ATP synthase,
(II-13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient,
(II-14) Nicotinic acetylcholine receptor (nAChR) channel blockers,
20 (II -15) Inhibitors of the chitin biosynthesis affecting CHS 1,
(II -16) Inhibitors of the chitin biosynthesis type 1,
(II -17) Moulting disruptors,
(II-18) Ecdyson receptor agonists,
(II-19) Octopamin receptor agonists,
25 (II-20) Mitochondrial complex III electron transport inhibitors,
(II-21) Mitochondrial complex I electron transport inhibitors,
(II-22) Voltage-dependent sodium channel blockers,
(II-23) Inhibitors of the acetyl CoA carboxylase,
(II-24) Mitochondrial complex IV electron transport inhibitors,
3
wo 2022/009058
(11-25) Mitochondrial complex II electron transport inhibitors,
(11-26) Ryanodine receptor-modulators,
(11-27) Chordotonal organ Modulators- undefined target site,
(11-28) GABA-gated chloride channel allosteric modulators,
5 (11-29) Baculoviruses,
PCT/IB2021/055992
(11-30) Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators -Site II,
(II-31) Insecticidal active compounds of unknown or uncertain mode of action,
(11-32) Biopesticides, and
(11-33) Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or
10 nematicidal activity.
Another aspect of the present invention provides a pesticidal active mixture comprising thietanyloxy
compound of formula (I), oxides or a salt thereof as a component (1) and a component (2) is at least
one fungicidally active compound (III) selected from the group consisting of:
(A) inhibitors of the ergosterol synthesis,
15 (B) inhibitors of the respiratory chain at complex I or II,
(C) inhibitors of the respiratory chain at complex III,
(D) inhibitors of the mitosis and cell division,
(E) compounds capable of having a multisite action,
(F) compounds capable of inducing a host defense,
20 (G) inhibitors of the amino acid and/or protein biosynthesis,
(H) inhibitors of the A TP production,
(I) inhibitors of the cell wall synthesis,
(J) inhibitors of the lipid and membrane synthesis,
(K) inhibitors of the melanine biosynthesis,
25 (L) inhibitors of the nucleic acid synthesis,
(M) inhibitors of the signal transduction,
(N) compounds capable of acting as uncoupler,
(0) other fungicides,
(P) HDAC inhibitors, and
30 (Q) compounds capable to act as a safener.
In yet another aspect, the present invention provides a method for controlling invertebrate pests and/or
phytopathogenic fungi of plants, comprising the step of applying a pesticidal active mixture to the pest
and/or microorganisms and/or their habitat including plants, plant parts, seeds, fruits or to the soil.
DETAILED DESCRIPTION OF THE INVENTION:
35 DEFINITIONS:
4
wo 2022/009058 PCT/IB2021/055992
In the definitions of the symbols given in the above formulae, collective terms were used which are
generally representative of the following substituents:
The term "hydrogen" encompasses also isotopes of hydrogen, preferably deuterium and tritium, more
preferably deuterium.
5 The term "halogen" (also in combinations such as haloalkyl, haloalkoxy etc.) encompasses fluorine,
chlorine, bromine and iodine, and preferably fluorine, chlorine, bromine.
The term "alkyl" (including in combinations such as alkylthio, alkoxy etc.) encompasses saturated,
straight -chain or branched hydrocarbyl radicals having 1 to 6 carbon atoms, for example C 1-C6-alkyl,
such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-
10 dimethylethyl, pentyl, 1-methylbutyl, 2- methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-
ethylpropyl, hexyl, 1 ,1-dimethylpropyl, 1 ,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-
methylpentyl, 4-methylpentyl, 1, 1-dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3-dimethylbutyl, 2,2-
dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1 ,2-
trimethylpropyl, 1 ,2,2-trimethylpropyl, l-ethyl-1-methylpropyl, l-ethyl-2-methylpropyl, heptyl and
15 octyl. If the alkyl is at the end of a composite substituent, as, for \example, in cycloalkyl-alkyl, the
part of the composite substituent at the start, for example the alkyl, may be mono- or polysubstituted
identically or differently and independently by cycloalkyl.
The term "cycloalkyl" means alkyl closed to form a ring. Non-limiting examples include but are not
limited to cyclopropyl, cyclopentyl and cyclohexyl. This definition also applies to cycloalkyl as a part
20 of a composite substituent, for example cycloalkyl-alkyl etc., unless specifically defined elsewhere.
Depending on the nature of the substituents, the compounds of formula (I) of the present invention or
the combining partner forming the part of pesticidal active mixture can be present as mixtures of
different possible isomeric forms, in particular of stereoisomers, such as, for example, E and Z, threo
and erythro, and also optical isomers, and, if appropriate, also of tautomers. If applicable, compounds
25 of formula (I) or the combining partner forming the part of pesticidal active mixture comprise both the
E and the Z isomers, and also the threo and erythro, and the optical isomers, any mixtures of these
isomers, and the possible tautomeric forms.
Any of the compounds of formula (I) or the combining partner forming the part of pesticidal active
mixture can exist in one or more optical, geometric or chiral isomer forms depending on the number
30 of asymmetric centres in the compound. The compound of formula (I) or the combining partner
forming the part of pesticidal active mixture include all the optical isomers and to their racemic or
scalemic mixtures (the term "scalemic" denotes a mixture of enantiomers in different proportions),
and to the mixtures of all the possible stereoisomers, in all proportions. The diastereomers and/or the
optical isomers can be separated according to the methods which are known per se by a person
35 ordinary skilled in the art.
5
wo 2022/009058 PCT/IB2021/055992
Any of the compounds of formula (I) or the combining partner forming the part of pesticidal active
mixture can also exist in one or more geometric isomer forms depending on the number of double
bonds in the compound. The compound of formula (I) or the combining partner forming the part of
pesticidal active mixture include all geometric isomers and to all possible mixtures, in all proportions.
5 The geometric isomers can be separated according to general methods, which are known per se by a
person ordinary skilled in the art.
Depending on the nature of the substituents, the compounds of formula (I) can also exist in one or
more geometric isomer forms depending on the relative position (syn/anti or cis/trans) of the
substituents of ring B. The invention thus relates equally to all syn/anti (or cis/trans) isomers and to all
10 possible syn/anti (or cis/trans) mixtures, in all proportions. The syn/anti (or cis/trans) isomers can be
separated according to general methods, which are known per se by the man ordinary skilled in the
art.
The compound of formula (I) can be reacted with acids to give salts.
Examples of inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride,
15 hydrogen bromide and hydrogen iodide, sulfuric acid, phosphoric acid and nitric acid, and acidic salts,
such as N aHS04 and KHS04.
Suitable organic acids are, for example, formic acid, carbonic acid and alkanoic acids, such as acetic
acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic
acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, alkylsulfonic acids
20 (sulfonic acids having straight-chain or branched alkyl groups having 1 to 20 carbon atoms),
arylsulfonic acids or disulfonic acids (aromatic groups, such as phenyl and naphthyl, which carry one
or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or
branched alkyl groups having 1 to 20 carbon atoms), arylphosphonic acids or diphosphonic acids
(aromatic radicals, such as phenyl and naphthyl, which carry one or two phosphonic acid groups),
25 where the alkyl and aryl groups may carry further substituents, for example p-toluenesulfonic acid,
salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc.
In view of the above, the present invention provides a pesticidal mixture comprising a mixture of at
least one pesticidally active comprising component (1) as thietanyloxy compound of formula (1),

CLAIM:
1. A pesticidal mixture comprising a mixture of at least one pesticidally active compound of formula
(1), as a component (1);
Formula (I)
wherein,
R1 is selected from the group consisting of C1-C6 alkyl, C3-Cs cycloalkyl, C3-Cs cycloalkyl-C1-C6
alkyl and C1-C6 alkyl-C3-Cs cycloalkyl;
R2 is selected from the group consisting of hydrogen and methyl;
10 R3 is selected from the group consisting of halogen and cyano;
R4 is selected from the group consisting of methyl, fluorine, chlorine, bromine and
trifluoromethyl;
R5 is selected from the group consisting of hydrogen, fluorine and chlorine;
R6 is selected from the group consisting of hydrogen, methyl and trifluoromethyl;
15 or agriculturally acceptable salts, isomers/structural isomers, stereo-isomers, diastereomers,
enantiomers, tautomers, metal complexes, polymorphs, or N-oxides thereof;
and at least one insecticidally active compound (II) and/or at least one fungicidally active
compound (III) as a component (2);
wherein at least one insecticidally active compound (II) selected from the group consisting of:
20 (Il-l) Acetylcholinesterase (AChE) inhibitors,
(II-2) GABA-gated chloride channel blockers,
(II-3) Sodium channel modulators,
(II-4) Nicotinic acetylcholine receptor (nAChR) competitive modulators,
(II-5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators- Site I,
25 (II-6) Glutamate-gated chloride channel (GluCl) allosteric modulators,
(II -7) Juvenile hormone mimics,
104
wo 2022/009058
(II -8) Miscellaneous non -specific (multi -site) inhibitors,
(11-9) Chordotonal organ TRPV channel modulators,
(II -1 0) Mite growth inhibitors affecting CHS 1,
(II -11) Microbial disruptors of insect midgut membranes,
5 (11-12) Inhibitors of mitochondrial ATP synthase,
PCT/IB2021/055992
(11-13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient,
(II -14) Nicotinic acetylcholine receptor (nAChR) channel blockers,
(II -15) Inhibitors of the chitin biosynthesis affecting CHS 1,
(II -16) Inhibitors of the chitin biosynthesis type 1,
10 (II -17) Moulting disruptors,
(II -18) Ecdyson receptor agonists,
(II -19) Octopamin receptor agonists,
(11-20) Mitochondrial complex III electron transport inhibitors,
(11-21) Mitochondrial complex I electron transport inhibitors,
15 (11-22) Voltage-dependent sodium channel blockers,
(11-23) Inhibitors of the acetyl CoA carboxylase,
(11-24) Mitochondrial complex IV electron transport inhibitors,
(11-25) Mitochondrial complex II electron transport inhibitors,
(11-26) Ryanodine receptor-modulators,
20 (11-27) Chordotonal organ Modulators- undefined target site,
(11-28) GABA-gated chloride channel allosteric modulators,
(11-29) Baculoviruses,
(11-30) Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators -Site II,
(II-31) Insecticidal active compounds of unknown or uncertain mode of action,
25 (11-32) Biopesticides, and
(11-33) Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or
nematicidal activity;
and at least one fungicidally active compound (III) selected from the group consisting of:
(A) inhibitors of the ergosterol synthesis,
30 (B) inhibitors of the respiratory chain at complex I or II,
(C) inhibitors of the respiratory chain at complex III,
(D) inhibitors of the mitosis and cell division,
(E) compounds capable of having a multisite action,
(F) compounds capable of inducing a host defense,
35 (G) inhibitors of the amino acid and/or protein biosynthesis,
(H) inhibitors of the A TP production,
105
wo 2022/009058
(I) inhibitors of the cell wall synthesis,
(J) inhibitors of the lipid and membrane synthesis,
(K) inhibitors of the melanine biosynthesis,
(L) inhibitors of the nucleic acid synthesis,
PCT/IB2021/055992
5 (M) inhibitors of the signal transduction,
(N) compounds capable of acting as uncoupler,
(0) other fungicides,
(P) HDAC inhibitors, and
(Q) compounds capable to act as a safener.
10 2. The pesticidal mixture according to claim 1, wherein the compound of formula (I) or oxides or salts
thereof as a component (1) is selected from (1-1) N-(2-(tert-butylcarbamoyl)-4-chloro-6-
methylphenyl)-1-(3-chloropyridin-2-yl)-3-( (1, 1-dioxidothietan-3-yl)oxy)-IH -pyrazole-5-
carboxamide; (1-2) N -(2-( tert -butylcarbamoyl)-4-chloro-6-methylphenyl)-1-(3-chloropyridin-2-yl)-3-
(thietan-3-yloxy)-IH-pyrazole-5-carboxamide; (1-3) N-(2-(tert-butylcarbamoyl)-4-cyano-6-
15 methylphenyl)-1-(3,5-dichloropyridin-2-yl)-3-(thietan-3-yloxy)-IH-pyrazole-5-carboxamide; (1-4) N(
4-chloro-2-(isopropylcarbamoyl)-6-methylphenyl)-1-(3-chloropyridin-2-yl)-3-(thietan-3-yloxy)-IHpyrazole-
5-carboxamide; (I -5) N -(2-(tert -butylcarbamoyl)-4-cyano-6-methylphenyl)-1-(3-
chloropyridin-2-yl)-3-( (3-methylthietan-3-yl)oxy)-IH -pyrazole-5-carboxamide; (1-6) N -(2-( tertbutylcarbamoyl)-
4-chloro-6-methylphenyl)-1-(3,5-dichloropyridin-2-yl)-3-(thietan-3-yloxy)-IH-
20 pyrazole-5-carboxamide; (1-7) N-(2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl)-1-(3-
chloropyridin-2-yl)-3-( (3-methyl-1, 1-dioxidothietan-3-yl)oxy)-IH-pyrazole-5-carboxamide; (1-8) 1-
(3-chloropyridin-2-yl )-N -(2,4-dichloro-6-(isopropylcarbamoyl )phenyl)-3-( ( 1, 1-dioxidothietan-3-
yl)oxy)-IH-pyrazole-5-carboxamide; (1-9) N-(2-bromo-4-chloro-6-(isopropylcarbamoyl)phenyl)-1-(3-
chloropyridin-2-yl)-3-( (1 ,1-dioxidothietan-3-yl)oxy)-IH-pyrazole-5-carboxamide; (1-10) N-( 4-chloro-
25 2-( cyclopropylcarbamoyl)-6-methylphenyl )-1-(3-chloro-5-fluoropyridin-2-yl)-3-( thietan-3-yloxy )IH-
pyrazole-5-carboxamide and (1-11) N-( 4-chloro-2-(isopropylcarbamoyl)-6-methylphenyl)-1-(3,5-
dichloropyridin-2-yl)-3-( ( 1, 1-dioxidothietan-3-yl)oxy)-IH -pyrazole-5-carboxamide.
3. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
insecticidally active compound (II) selected from:
30 (11-1) Acetylcholinesterase (AChE) inhibitors selected from the class of
35
(Il-IA) carbamates including alanycarb (ZOOI), aldicarb (Z002), bendiocarb (Z003),
benfuracarb (Z004), butocarboxim (ZOOS), butoxycarboxim (Z006), carbaryl (Z007),
carbofuran (ZOOS), carbosulfan (Z009), ethiofencarb (ZOIO), fenobucarb (ZOll),
formetanate (Z012), furathiocarb (Z013), isoprocarb (Z014), methiocarb (Z015),
methomyl (Z016), metolcarb (Z017), oxamyl (Z018), pirimicarb (Z019), propoxur (Z020),
106
wo 2022/009058 PCT/IB2021/055992
thiodicarb (Z021), thiofanox (Z022), triazamate (Z023), trimethacarb (Z024), XMC
(Z025), and xylylcarb (Z026); or
(11-IB) organophosphates including acephate (Z027), azamethiphos (Z028), azinphos-ethyl
(Z029), azinphosmethyl (Z030), cadusafos (Z031), chlorethoxyfos (Z032),
5 chlorfenvinphos (Z033), chlormephos (Z034), chlorpyrifos (Z035), chlorpyrifos-methyl
(Z036), coumaphos (Z037), cyanophos (Z038), demeton-s-methyl (Z039), diazinon
(Z040), dichlorvos/ddvp (Z041), dicrotophos (Z042), dimethoate (Z043), dimethylvinphos
(Z044), disulfoton (Z045), epn (Z046), ethion (Z047), ethoprophos (Z048), famphur
(Z049), fenamiphos (Z050), fenitrothion (Z051), fenthion (Z052), fosthiazate (Z053),
10
15
heptenophos (Z054), imicyafos (Z055), isofenphos (Z056), isopropyl o(
methoxyaminothio-phosphoryl) salicylate (Z057), isoxathion (Z058), malathion (Z059),
mecarbam (Z060), methamidophos (Z061), methidathion (Z062), mevinphos (Z063),
monocrotophos (Z064), naled (Z065), omethoate (Z066), oxydemeton-methyl (Z067),
parathion (Z068), parathion-methyl (Z069), phenthoate (Z070), phorate (Z071), phosalone
(Z072), phosmet (Z073), phosphamidon (Z074), phoxim (Z075), pirimiphos-methyl
(Z076), profenofos (Z077), propetamphos (Z078), prothiofos (Z079), pyraclofos (Z080),
pyridaphenthion (Z081), quinalphos (Z082), sulfotep (Z083), tebupirirnfos (Z084),
temephos (Z085), terbufos (Z086), tetrachlorvinphos (Z087), thiometon (Z088), triazophos
(Z089), trichlorfon (Z090), and vamidothion (Z091);
20 (11-2) GABA-gated chloride channel blockers selected from the class of
(II-2A) Cyclodiene Organochlorines including chlordane (Z092) and endosulfan (Z093); or
(II-2B) Phenylpyrazoles (Fiproles) including ethiprole (Z094), fipronil (Z095), flufiprole (Z096),
pyrafluprole (Z097) and pyriprole (Z0918;
(11-3) Sodium channel modulators selected from the class of
25 (II-3A) Pyrethroids/Pyrethrins including acrinathrin (Z099), allethrin (ZIOO), d-cis-trans allethrin
30
35
(ZIOI), d-trans-allethrin (Z102), bifenthrin (Z103), bioallethrin (Z104), bioallethrin scyclopentenyl
isomer (Z105), bioresmethrin (Z106), cycloprothrin (Z107), cyfluthrin
(Z108), beta-cyfluthrin (Z109), cyhalothrin (ZllO), lambda-cyhalothrin (Zlll), gammacyhalothrin
(Zl12), cypermethrin (Z113), alpha-cypermethrin (Zl14), beta-cypermethrin
(Z115), theta-cypermethrin (Z116), zeta-cypermethrin (Zll7), cyphenothrin [(lr)-transisomers
(Z118), deltamethrin (Z119), empenthrin [(ez)-(lr)-isomers] (Z120), esfenvalerate
(Z121), etofenprox (Z122), fenpropathrin (Z123), fenvalerate (Z124), flucythrinate (Z125),
flumethrin (Z126), tau-fluvalinate (Z127), halfenprox (Z128), imiprothrin (Z129),
meperfluthrin (Z130), metofluthrin (Z131), momfluorothrin (Z132), kadethrin (Z133),
permethrin (Z134), phenothrin [(lr)-trans-isomer] (Z134), prallethrin (Z135), profluthrin
(Z136), pyrethrins (pyrethrum) (Z137), resmethrin (Z138), silafluofen (Z139), tefluthrin
107
wo 2022/009058 PCT/IB2021/055992
(Z140), tetramethylfluthrin (Z141), tetramethrin (Z142), tetramethrin [(lr)-isomers]
(Z143), tralomethrin (Z144) and transfluthrin (Z145); or
(II-3B) DDT (Z146) or methoxychlor (Z147)
(11-4) Nicotinic acetylcholine receptor (nAChR) competitive modulators selected from the class
5 of
10
(II-4A) Neonicotinoids including acetamiprid (Z148), clothianidin (Z149), dinotefuran (Z150),
imidacloprid (Z151), nitenpyram (Z152), thiacloprid (Z153), thiamethoxam (Z154), 1-
[(6-chloro-3-pyridinyl)methyl]-2,3,5,6,7,8-hexahydro-9-nitro-(5S,8R)-5,8-epoxy-Himidazo[
1 ,2-a]azepine (Z155); 1-[(6-chloro-3-pyridyl)methyl]-2-nitro-1-[(E)-
pentylideneamino ]guanidine (Z156); and 1-[(6-chloro-3-pyridyl)methyl]-7 -methyl-8-
nitro-5-propoxy-3,5,6,7-tetrahydro-2H-imidazo[1,2-a]pyridine (Z157); or
(II-4B) Nicotine (Z158); or
(II-4C) Sulfoximines including sulfoxaflor (Z159); or
(II-4D) Butenolides including flupyradifurone (Z160); or
15 (II-4E) Mesoionics including triflumezopyrim (Z161), and dichloromezotiaze (Z162),
(II-4F) Flupyrimin (Z163),
20
(11-5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators - Site I selected from the
class of spinosyns including spinetoram (Z164) and spinosad (Z165),
(11-6) Glutamate-gated chloride channel (GluCl) allosteric modulators selected from the class
avermectins/Milbemycins including abamectin (Z166), emamectin benzoate (Z167),
lepimectin (Z168) and milbemectin (Z169),
(11-7) Juvenile hormone mimics selected from the class of
(11-7 A) Juvenile hormone analogues including hydroprene (Z170), kinoprene (Zl71) and
methoprene (Z172); or
25 (II-7B) Fenoxycarb (Z173); or
(II-7C) Pyriproxyfen (Z174),
(11-8) Miscellaneous non-specific (multi-site) inhibitors selected from the class of
(II-8A) Alkyl halides including methyl bromide (Z175) and other alkyl halides (Z176); or
(II-8B) Chloropicrin (Z177); or
30 (II-8C) Fluorides including cryolite (sodium aluminium fluoride) (Zl78) and sulfuryl fluoride
(Z179); or
(II-8D) Borates including borax (Z180), boric acid (Z181), disodium octaborate (Z182), sodium
borate (Z183), and sodium metaborate (Z184); or
(II-8E) Tartar emetic (Z185); or
35 (II-8F) Methyl isothiocyanate generators including dazomet (Z186) and metam (Z187),
(11-9) Chordotonal organ TRPV channel modulators selected from the class of
108
wo 2022/009058 PCT/IB2021/055992
(II-9A) Pyridine azomethine derivatives including pymetrozine (Z188), and pyrifluquinazon
(Z189); or
(II-9B) Pyropenes including afidopyropen (Z190),
(II -1 0) Mite growth inhibitors affecting CHS 1 selected from the class of
5 (II- lOA) Clofentezine (Z191), Hexythiazox (Z192) and Diflovidazin (Z193); or
(II- lOB) Etoxazole (Z194),
(II -11) Microbial disruptors of insect midgut membranes selected from the class of
(II-llA) Bacillus thuringiensis (Z195) and the insecticidal proteins they produce, including
bacillus thuringiensis or bacillus sphaericus (Z 196) and the insecticdal proteins they produce
10 such as bacillus thuringiensis subsp. Israelensis, bacillus thuringiensis subsp. Aizawai, bacillus
thuringiensis subsp. kurstaki and bacillus thuringiensis subsp. Tenebrionis, or the B.t crop
proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb
and Cry34/35Ab1,
(II -12) Inhibitors of mitochondrial A TP synthase selected from the class of
15 (II -12A) Diafenthiuron (Z 197); or
(II-12B) Organotin miticides including azocyclotin (Z198), cyhexatin (Z199) and fenbutatin
oxide (Z200), or
(II-12C) Propargite (Z201), or
(II-12D) Tetradifon (Z202),
20 (11-13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient selected
from the class of
(II-13A) Pyrroles including chlorfenapyr (Z203); or
(II-13B) Dinitrophenols including DNOC (Z204); or
(II -13C) Sulfluramid (Z205),
25 (II -14) Nicotinic acetylcholine receptor (nAChR) channel blockers selected from the class of
nereistoxin analogues including bensultap (Z206), cartap hydrochloride (Z207), thiocyclam
(Z208) and thiosultap-sodium (Z209),
(II -15) Inhibitors of the chitin biosynthesis affecting CHS 1 selected from the class of bzoylureas
including bistrifluron (Z210), chlorfluazuron (Z211), diflubenzuron (Z212), flucycloxuron
30 (Z213), flufenoxuron (Z214), hexaflumuron (Z215), lufenuron (Z216), novaluron (Z217),
noviflumuron (Z218), teflubenzuron (Z219) and triflumuron (Z220),
(II -16) Inhibitors of the chitin biosynthesis type 1 including buprofezin (Z221 ),
(II -17) Moulting disruptors, Dipteran, including cyromazine (Z222),
(II -18) Ecdyson receptor agonists selected from the class of diacylhydrazines including
35 methoxyfenozide (Z223), tebufenozide (Z224), halofenozide (Z225), fufenozide (Z226) and
chromafenozide (Z227);
(II -19) Octopamin receptor agonists, including amitraz (Z228),
109
wo 2022/009058 PCT/IB2021/055992
(11-20) Mitochondrial complex III electron transport inhibitors selected from the class of
(II-20A) Hydramethylnon (Z229); or
(II-20B) Acequinocyl (Z230); or
(II-20C) Fluacrypyrim (Z231); or
5 (II-20D) Bifenazate (Z232),
(11-21) Mitochondrial complex I electron transport inhibitors selected from the class of
(II-21A) METI acaricides and insecticides including fenazaquin (Z233), fenpyroximate (Z234),
pyrimidifen (Z235), pyridaben (Z236), tebufenpyrad (Z237) and tolfenpyrad (Z238); or
(II-21B) Rotenone (Z239),
10 (11-22) Voltage-dependent sodium channel blockers selected from the class of
(II-22A) Oxadiazines including indoxacarb (Z240); or
(II-22B) Semicarbazones including metaflumizone (Z241); or
(II-22C) 1-[(E)-[2-( 4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene ]amino ]-3-[ 4-
( difluoromethoxy)phenyl ]urea (Z242),
15 (II -22D) 2-[3-( ethanesulfonyl)pyridin-2-yl] -5-[trifluoro(methanesulfonyl)] -1 ,3-benzoxazole
( oxazosulfyl) (Z243),
(11-23) Inhibitors of the acetyl CoA carboxylase selected from the class of tetronic and Tetramic
acid derivatives including spirodiclofen (Z244), spiromesifen (Z245), spiropidion (Z246), and
spirotetramat (Z247),
20 (11-24) Mitochondrial complex IV electron transport inhibitors selected from the class of
(II-24A) Phosphides including aluminium phosphide (Z248), calcium phosphide (Z249),
phosphine (Z250) and zinc phosphide (Z251); or
(II-24B) Cyanides including calcium cyanide (Z252), potassium cyanide (Z253) and sodium
cyanide (Z254),
25 (11-25) Mitochondrial complex II electron transport inhibitors selected from the class of
(II-25A) Beta-ketonitrile derivatives including cyenopyrafen (Z255) and cyflumetofen (Z256), or
(II-25B) Caboxanilides including pyflubumide (Z257),
(11-26) Ryanodine receptor-modulators from the class of diamides including flubendiamide
(Z258), chlorantraniliprole (Rynaxypyr®) (Z259), cyantraniliprole (Cyazypyr®) (Z260),
30 cyclaniliprole (Z260), tetraniliprole (Z261), tetra-chlorantraniliprole (Z262), (R)-3-Chlor-Nl-{2-
methyl-4-[1 ,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl} -N2-(l-methyl-2-
methylsulfonylethyl)phthalamid (Z263); (S)-3-Chlor-Nl-{ 2-methyl-4-[1 ,2,2,2-tetrafluor-1-
(trifluormethyl)ethyl ]phenyl}-N2-( 1-methyl-2-methylsulfonylethyl)phthalamid (Z264 ); methyl-
2-[3,5-dibromo-2-( { [3-bromo-1-(3-chlorpyridin-2-yl)-IH-pyrazol-5-
35 yl]carbonyl }amino )benzoyl]-! ,2-dimethylhydrazinecarboxylate (Z265); N-[2-(5-amino-1 ,3,4-
thiadiazol-2-yl)-4-chloro-6-methyl-phenyl]-5-bromo-2-(3-chloro-2-pyridyl)pyrazole-3-
carboxamide (Z266); 5-chloro-2-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[(1-cyano-1-methyl-
110
wo 2022/009058 PCT/IB2021/055992
ethyl )carbamoyl ]phenyl ]pyrazole-3-carboxamide (Z267); 5 -bromo-N-[2,4-dichloro-6-
(methylcarbamoyl)phenyl]-2-(3,5-dichloro-2-pyridyl)pyrazole-3-carboxamide (Z268); N-[2-(tertbutylcarbamoyl)-
4-chloro-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(fluoromethoxy)pyrazole-
3-carboxamide (Z269); N2-(l-cyano-1-methyl-ethyl)-N1-(2,4-dimethylphenyl)-3-iodo-
5 phtha1amide (Z270); and 3-chloro-N2-(l-cyano-1-methyl-ethyl)-N1-(2,4-
dimethylphenyl)phthalamide (Z271),
(11-27) Chordotonal organ Modulators- undefined target site including flonicamid (Z272),
(11-28) GABA-gated chloride channel allosteric modulators selected from the class of
(II-28A) Meta-diamides including broflanilide (Z273); or
10 (II-28B) Isoxazolines including fluxametamide (Z274); Isocycloseram (Z275),
(11-29) Baculoviruses selected from the class of
(II-29A) Granuloviruses (GVs) including cydia pomonella GV (Z276) and Thaumatotibia
leucotreta GV (Z277); or
(II-29B) Nucleopolyhedroviruses (NPVs) including anticarsia gemmatalis MNPV (Z278), and
15 helicoverpa armigera NPV (Z279),
(11-30) Nicotinic Acetylcholine Receptor (nAChR) Allosteric Modulators - Site II including GS
omega/kappa HXTX-Hv1a peptide (Z280),
(II-31) Insecticidal active compounds of unknown or uncertain mode of action including
Afidopyropen (Z281), azadirachtin (Z282), amidoflumet (Z283), benzoximate (Z284),
20 benzpyrimoxan (Z285), bifcnazate (Z286), bromopropylate (Z287), chinomethionat (Z288),
cryolite (Z289), dicofol (Z290), flufenerim (Z291), flometoquin (Z292), fluhexafon (Z293),
fluensulfone (Z294), flupyradifurone (Z295), lime sulphur (Z296), mancozeb (Z297), piperonyl
butoxide (Z298), pyridalyl (Z299), pyrifluquinazon (Z300), sulfoxaflor (Z301), sulphur (Z302),
4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-[(2,2,2-
25 trifluoro-ethylcarbamoyl)-methyl]-benzamide (Z303); cyclopropaneacetic acid (Z304); 1, 1'-
[ (3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-4-[[ (2-cyclopropylacetyl)oxy ]methyl]-
1 ,3,4,4a,5,6,6a, 12, 12a,12b-decahydro-12-hydroxy-4,6a,12b-trimethyl-11-oxo-9-(3-pyridinyl)-
2H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-3,6-diyl]ester (Z305); 11-( 4-chloro-2,6-
dimethylphenyl)-12-hydroxy-1 ,4-dioxa-9-azadispiro[ 4.2.4.2]-tetradec-11-en-10-one (Z306); 3-
30 ( 4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy -8-oxa-1-azaspiro[ 4.5]dec-3-en-2-one (Z307);
1-[2-fluoro-4-methyl-5-[ (2,2,2-trifluoroethyl)sulfinyl ]phenyl]-3-( trifluoromethyl)-1H -1,2,4-
triazo1e-5-amine (Z308); or actives on basis of bacillus firmus (Votivo, 11-1582) (Z309); (E/Z)N
-[1-[ ( 6-chloro-3-pyridyl)methyl] -2-pyridylidene] -2,2,2-trifluoro-acetamide (Z31 0); (E/Z)-N-
[1-[ ( 6-chloro-5-flu oro-3-pyridyl)methyl] -2-pyridylidene] -2,2,2-trifluoro-acetamide (Z311 );
35 (E/Z)-2,2,2-trifluoro-N -[ 1-[ ( 6-flu oro-3-pyridyl)methyl ]-2-pyridylidene ]acetamide (Z312);
(E/Z)-N -[ 1-[ ( 6-bromo-3-pyridyl)methyl] -2-pyridylidene] -2,2,2-trifluoro-acetamide (Z313);
(E/Z)-N -[ 1-[1-( 6-chloro-3-pyridyl)ethyl] -2-pyridylidene] -2,2,2-trifluoro-acetamide (Z314 );
111
wo 2022/009058 PCT/IB2021/055992
(E/Z)-N -[ 1-[ ( 6-chloro-3-pyridyl)methyl] -2-pyridylidene] -2,2-difluoro-acetamide (Z315); (E/Z)-
2-chloro-N -[1-[ ( 6-chloro-3-pyridyl)methyl] -2-pyridylidene] -2,2-difluoro-acetamide (Z316);
(E/Z)-N -[ 1-[ (2-chloropyrimidin -5-yl)methyl] -2-pyridylidene ]-2,2,2-trifluoro-acetamide (Z317);
(E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propanamide)
5 (Z318); triflumezopyrim (Z319); 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-
4H -isoxazol-3-yl]-N -[2-oxo-2-(2,2,2-trifluoroethylamino )ethyl]naphthalene-1-carboxamide
(Z312); 3-[3-chloro-5-(trifluoromethyl)phenyl] -4-oxo-1-(pyrimidin-5-ylmethyl)pyrido[l ,2-
a]pyrimidin-1-ium-2-olate (Z313); 8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-
trifluoromethyl)-imidazo[ 1 ,2-a ]pyridine-2-carboxamide (Z314 ); 4-[ 5-(3,5-dichlorophenyl)-5-
10 (trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(l-oxothietan-3-yl)benzamide (Z315); 5-[3-[2,6-
dichloro-4-(3,3-dichloroallyloxyl)phenoxy ]propoxy] -IH -pyrazole(Z316);
(Z317), ;Tyclopyrazoflor (Z318) and Nicofluprole (Z319),
Dimpropyridaz
(11-32) Biopesticides selected from the class of Microbial pesticides with insecticidal, acaricidal,
molluscidal and/or nematicidal activity including Bacillus firmus (Z320), B.t. ssp. galleriae, B.t.
15 ssp. kurstaki, Beauveria bassiana (Z321), Burkholderia sp. (Z322), Chromobacterium subtsugae
(Z323), Isaria fumosorosea (Z324), Lecanicillium longisporum (Z325), L. muscarium (formerly
Verticillium lecanii) (Z326), Metarhizium anisopliae (Z327), M. anisopliae var. acridum
(Z328), Paecilomyces fumosoroseus Apopka strain 97 (Z329), P. lilacinus (Z330), Paenibacillus
poppiliae (Z331), Pasteuria spp. (Z332), P. nishizawae (Z333), P. reneformis (Z334), P. usagae
20 (Z335), Pseudomonas fluorescens (Z336), Steinernema feltiae (Z337), Streptomces galbus
(Z338), Wolbachia pipientis (Zap) (Z339) Bacillus amyloliquefaciens (Z373 ), Bacillus subtilis
(Z374), Lecanicillium lecanii (Z375), Purpureocillium lilacinum (Z376) and Burkholderia
rinojenses (Z377),and
(11-33) Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or
25 nematicidal activity including L-carvone (Z340); citral (Z341); (E,Z)-7,9-dodecadien-1-yl acetate
(Z342); ethyl formate (Z343); (E,Z)-2,4-ethyl decadienoate (pear ester) (Z344); (Z,Z,E)-7,11,13-
hexadecatrienal (Z345); heptyl butyrate (Z346); isopropyl myristate (Z347); lavanulyl senecioate
(Z348); 2-methyl !-butanol (Z349); methyl eugenol (Z350); methyl jasmonate (Z351); (E,Z)-
2,13-octadecadien-1-ol (Z352); (E,Z)-2,13-octadecadien-1-ol acetate (Z353); (E,Z)-3,13-
30 octadecadien-1-ol (Z354), R-1-octen-3-ol (Z355); pentatermanone (Z356); potassium silicate
(Z357); sorbitol actanoate (Z358); (E,Z,Z)-3,8,11-tetradecatrienyl acetate (Z359); (Z,E)-9,12-
tetradecadien -1-yl acetate (Z360); Z-7 -tetradecen-2-one (Z361), Z-9-tetradecen -1-yl acetate
(Z362); Z-11-tetradecenal (Z363); Z-11-tetradecen-1-ol (Z364); Acacia negra extract (Z365);
extract of grapefruit seeds and pulp (Z366); extract of Chenopodium ambrosiodae (Z367); fatty
35 acid monoester with glycerol or propanediol (Z368), Catnip oil (Z369); Neem oil (Z370); Quillay
extract (Z371) and Tagetes oil (Z372).
112
5
10
15
20
25
30
35
wo 2022/009058 PCT/IB2021/055992
4. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
fungicidally active compound (III) selected from the groups A) toP):
(A) Inhibitors of the ergosterol biosynthesis including (A001) cyproconazole; (A002)
difenoconazole; (A003) epoxiconazole; (A004) fenhexamid; (A005) fenpropidin; (A006)
fenpropimorph; (A007) fenpyrazamine; (A008) fluquinconazole; (A009) flutriafol; (AOIO)
imazalil; (AOll) imazalil sulfate; (A012) ipconazole; (A013) metconazole; (A014)
myclobutanil; (A015) paclobutrazol; (A016) prochloraz; (A017) propiconazole; (A018)
prothioconazole; (A019) pyrisoxazole; (A020) spiroxamine; (A021) tebuconazole; (A022)
tetraconazole; (A023) triadimenol; (A024) tridemorph; (A025) triticonazole; (A026)
(1R,2S,5S)-5-( 4-chlorobenzyl)-2-( chloromethyl)-2-methyl-l-(lH -1 ,2,4-triazoll-
ylmethyl)cyclopentanol; (A027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-
1-(1H-1,2,4-triazol-l-ylmethyl)cyclopentanol, (A028) (2R)-2-(l-chlorocyclopropyl)-4-
[(1R)-2,2-dichlorocyclopropyl]-l-(lH-1,2,4-triazol-l-yl)butan-2-ol; (A029) (2R)-2-(lchlorocyclopropyl)-
4-[(lS)-2,2-dichlorocyclopropyl]-1-(lH-1 ,2,4-triazol-1-yl)butan-2-ol;
(A030) (2R)-2-[ 4-( 4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(IH-1 ,2,4-triazol-1-
yl)propan-2-ol; (A031) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-
(1H-l,2,4-triazol-1-yl)butan-2-ol; (A032) (2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-
dichlorocyclopropyl]-1-(1H-1 ,2,4-triazol-1-yl)butan-2-ol; (A033) (2S)-2-[ 4-( 4-
chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(lH-1 ,2,4-triazol-1-yl)propan-2-ol; (A034) (R)[
3-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol;
(A035) (S)-[3-( 4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl] (pyridin-3-
yl)methanol; (A036) [3- ( 4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1 ,2-oxazol-4-
yl](pyridin-3-yl)methanol; (A037) 1-( { (2R,4S)-2-[2-chloro-4-( 4-chlorophenoxy)phenyl]-4-
methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; (A038) 1-( { (2S,4S)-2-[2-chloro-4-( 4-
chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-lH-1,2,4-triazole; (A039) 1-
{ [3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl ]methyl} -lH -1 ,2,4-triazol-5-yl
thiocyanate; (A040) 1-{ [ rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran -2-
yl]methyl }-1H-1 ,2,4-triazol-5-yl thiocyanate; (A041) 1-{ [rel(2R,3S)-3-(2-chlorophenyl)-2-
(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate; (A042) 2-
[ (2R,4 R,5R)-1-(2,4-dichlorophenyl )-5-hydroxy-2,6,6-trimethylheptan -4-yl]-2,4-dihydro-3H-
1 ,2,4-triazole-3-thione; (A043) 2-[ (2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-
trimethylheptan-4-yl] -2,4-dihydro-3H -1 ,2,4-triazole-3-thione; (A044) 2-[ (2R,4S,5R)-l-(2,4-
dichlorophenyl )-5-hydroxy-2,6,6-trimethylheptan -4-yl]-2,4-dihydro-3H -1 ,2,4-triazole-3-
thione; (A045) 2-[(2R,4S,5S)-l-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-
2,4-dihydro-3H-1 ,2,4-triazole-3-thione; (A046) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-
hydroxy-2,6,6-trimethylheptan-4-yl] -2,4-dihydro-3H -1 ,2,4-triazole-3-thione; (A04 7) 2-
[ (2S,4 R,5S)-1-(2,4-dichlorophenyl )-5-hydroxy-2,6,6-trimethylheptan -4-yl]-2,4-dihydro-3H-
113
5
10
15
20
25
30
35
wo 2022/009058 PCT/IB2021/055992
1 ,2,4-triazole-3-thione; (A048) 2-[ (2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-
trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione; (A049) 2-[(2S,4S,5S)-l-
(2, 4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan -4-yl]-2,4-dihydro-3H -1 ,2,4-triazole-3-
thione; (A050) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-
3H-1,2,4-triazole-3-thione; (A051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-l-(1H-
1 ,2,4-triazol-1-yl)propan-2-ol; (A052) 2-[2-chloro-4-( 4-chlorophenoxy)phenyl]-1-(lH-1 ,2,4-
triazol-1-yl)butan-2-ol; (A053) 2-[ 4-( 4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(lH-
1 ,2,4-triazol-1-yl)butan-2-ol; (A054) 2-[ 4-( 4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-
1-(1 H -1 ,2,4-triazol-l -yl )pen tan-2-ol; (A05 5) 2-[ 4-( 4-chlorophenoxy )-2-
(trifluoromethyl)phenyl]-1-(lH-1,2,4-triazol-1-yl)propan-2-ol; (A056) 2-{ [3-(2-
ch1orophenyl )-2-(2,4-difluorophenyl)oxiran-2-yl ]methyl}-2,4-dihydro-3H -1,2,4-triazole-3-
thione; (A057) 2- { [ rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-
yl ]methyl} -2,4-dihydro-3H -1 ,2,4-triazole-3-thione; (A058) 2-{ [rel(2R,3S)-3-(2-
ch1orophenyl )-2-(2,4-difluorophenyl)oxiran-2-yl ]methyl}-2,4-dihydro-3H -1,2,4-triazole-3-
thione; (A059) 5-( 4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(lH-1 ,2,4-triazol-1-
ylmethyl)cyclopentanol; (A060) 5-(allylsulfanyl)-1-{ [3-(2-chlorophenyl)-2-(2,4-
difluorophenyl)oxiran-2-yl]methyl }-1H-1 ,2,4-triazole; (A061) 5-(allylsulfanyl)-1-
{ [ rel(2R,3R)-3-2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl ]methyl} -1H -1 ,2,4-triazole;
(A062) 5-( allylsulfanyl)-1- { [ rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran -2-
yl]methyl}-1H-1,2,4-triazole; (A063) N'-(2,5-dimethyl-4-{ [3-(1,1,2,2-
tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide; (A064) N'(
2,5-dimethyl-4-{ [3-(2,2,2-trifluoroethoxy )phenyl] sulfanyl} phenyl)-N -ethyl-Nmethylimidoformamide;
(A065) N'-(2,5-dimethyl-4-{ [3-(2,2,3,3-
tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamide; (A066) N'(
2,5-dimethyl-4-{ [3-(pentafluoroethoxy)phenyl ]sulfanyl} phenyl)-N -ethyl-Nmethylimidoformamide;
(A067) N' -(2,5-dimethyl-4-{ 3-[ ( 1 ,1,2,2-
tetrafluoroethyl)sulfanyl ]phenoxy} phenyl)-N -ethyl-N -methylimidoformamide; (A068) N'(
2,5-dimethyl-4-{ 3-[ (2,2,2-trifluoroethyl)sulfanyl ]phenoxy} phenyl)-N -ethyl-Nmethylimidoformamide;
(A069) N'-(2,5-dimethyl-4-{3-[(2,2,3,3-
tetrafluoropropyl)sulfanyl]phenoxy }phenyl)-N-ethyl-N-methylimidoformamide; (A070) N'(
2,5-dimethyl-4-{ 3-[ (pentafluoroethyl)sulfanyl]phenoxy} phenyl)-N -ethyl-Nmethylimidoformamide;
(A071) N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-Nmethylimidoformamide;
(A072) N'-( 4-{ [3-(difluoromethoxy)phenyl]sulfanyl} -2,5-
dimethylphenyl)-N-ethyl-N-methylimidoformamide; (A073) N'-(4-{3-
[ ( difluoromethyl)sulfanyl ]phenoxy} -2,5-dimethylphenyl)-N -ethyl-N -methylimidoformamide;
(A074) N'-[5-bromo-6-(2,3-dihydro-lH-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethylN-
methylimidoformamide; (A075) N'-{ 4-[( 4,5-dichloro-1 ,3-thiazol-2-yl)oxy ]-2,5-
114
5
10
15
20
25
30
35
wo 2022/009058 PCT/IB2021/055992
dimethylphenyl}-N-ethyl-N-methylimidoformamide; (A076) N'-{S-bromo-6-[(1R)-I-(3,Sdifluorophenyl)
ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide; (A077)
N'-{ S-bromo-6-[ (I S)-I-(3,S-difluorophenyl)ethoxy] -2-methylpyridin-3-yl}-N -ethyl-Nmethylimidoformamide;
(A07S) N'-{ S-bromo-6-[ ( cis-4-isopropylcyclohexyl)oxy] -2-
methylpyridin-3-yl}-N-ethyl-N-methylimidoformamide; (A079) N'-{S-bromo-6-[(trans-4-
isopropylcyclohexyl )oxy]-2-methylpyridin-3-yl}-N -ethy 1-N-methylimidoformamide; (AOSO)
N'-{ S-bromo-6-[I-(3,S-difluorophenyl)ethoxy] -2-methylpyridin-3-yl}-N -ethyl-Nmethylimidoformamide;
(AOSI) mefentrifluconazole; (AOS2) ipfentrifluconazole; (AOS3) I(
2,4-difluorophenyl)-2-(IH-I ,2,4-triazol-I-yl)-I-[I-(2,6-difluoro-4-
chiorophenoxy)cyclopropyl]ethanol; and (AOS4) I-[2-(l-chlorocyclopropyl)-3-(2-
fluorophenyl )-2-hydroxypropyl] -I H-imidazole-S-carbonitrile,
(B) Inhibitors of the respiratory chain at complex I or II including (BOO I) benzovindiflupyr;
(B002) bixafen; (B003) boscalid; (B004) carboxin; (BOOS) fluopyram; (B006) flutolanil;
(B007) fluxapyroxad; (BOOS) furametpyr; (B009) isofetamid; (BOlO) isopyrazam (antiepimeric
enantiomer IR,4S,9S); (BOll) isopyrazam (anti-epimeric enantiomer IS,4R,9R);
(BOI2) isopyrazam (anti-epimeric racemate IRS,4SR,9SR); (B013) isopyrazam (mixture of
syn-epimeric racemate IRS,4SR,9RS and anti-epimeric racemate IRS,4SR,9SR); (BOI4)
isopyrazam (syn-epimeric enantiomer IR,4S,9R); (BOIS) isopyrazam (syn-epimeric
enantiomer IS,4R,9S); (BOI6) isopyrazam (syn-epimeric racemate IRS,4SR,9RS); (BOI7)
penflufen; (BOIS) penthiopyrad; (BOI9) pydiflumetofen; (B020) pyraziflumid; (B02I)
sedaxane; (B022) I ,3-dimethyl-N -(I, I ,3-trimethyl-2,3-dihydro-lH -inden-4-yl)-lH-pyrazole-4-
carboxamide; (B023) I ,3-dimethyl-N-[(3R)-l,l,3-trimethyl-2,3-dihydro-IH-inden-4-yl]-IHpyrazole-
4-carboxamide; (B024) l,3-dimethyl-N-[(3S)-I,I,3-trimethyl-2,3-dihydro-lH-inden-
4-yl]-IH-pyrazole-4-carboxamide; (B02S) l-methyl-3-(trifluoromethyl)-N-[2'-
(trifluoromethyl)biphenyl-2-yl ]-IH -pyrazole-4-carboxamide; (B026) 2-fluoro-6-
(trifluoromethyl)-N-(I,I,3-trimethyl-2,3-dihydro-lH-inden-4-yl)benzamide; (B027) 3-
( difluoromethyl)-I-methyl-N -(I, I ,3-trimethyl-2,3-dihydro-IH -inden-4-yl)-lH -pyrazole-4-
carboxamide; (B02S) 3-( difluoromethyl)-I-methyl-N -[ (3R)-I, I ,3-trimethyl-2,3-dihydrolH-
inden-4-yl]-lH-pyrazole-4-carboxamide; (B029) 3-( difluoromethyl)-I-methyl-N-[(3S)I,
I,3-trimethyl-2,3-dihydro-lH-inden-4-yl]-lH-pyrazole-4-carboxamide; (B030) 3-
(difluoromethyl)-N-(7 -fluoro-I, I ,3- trimethyl-2,3-dihydro-lH-inden-4-yl)-I-methyl-IHpyrazole-
4-carboxamide (Fluindapyr); (B03I) 3- (difluoromethyl)-N-[(3R)-7-fluoro-l,I,3-
trimethyl-2,3-dihydro-lH-inden-4-yl]-I-methyl-IH-pyrazole-4-carboxamide; (B032) 3-
(difluoromethyl)-N-[(3S)-7-fluoro-I, I ,3-trimethyl-2,3-dihydro-IH-inden-4- yl]-I-methyl- l
H -pyrazole-4-carboxamide; (B033) S ,S-difluoro-N -[2-(2-fluoro-4- { [ 4-
(trifluoromethyl)pyridin-2-yl]oxy }phenyl)ethyl]quinazolin-4-amine; (B034) N-(2-
cyclopentyl-S-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-S-fluoro-I-methyl-l-H-
115
5
10
15
20
25
30
wo 2022/009058 PCT/IB2021/055992
pyrazole-4-carboxamide; (B035) N -(2-tert -butyl-5-methylbenzyl)-N -cyclopropyl-3-
(difluoromethyl)-5-fluoro-1-methyl-IH-pyrazole-4-carboxamide; (B036) N -(2-tertbutylbenzyl)-
N -cyclopropyl-3-( difluoromethyl)-5-fluoro-1-methyl-IH -pyrazole-4-
carboxamide; (B037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-
1-methyl-IH-pyrazole-4-carboxamide; (B038) N-(5-chloro-2-isopropylbenzyl)-Ncyclopropyl-
3-( difluoromethyl)-5-fluoro-1-methyl-lH-pyrazole-4-carboxamide; (B039) N[
( 1R,4S)-9-( dichloromethylene )-1 ,2,3,4-tetrahydro-1 ,4-methanonaphthalen-5-yl]-3-
(difluoromethyl)-1-methyl-IH-pyrazole-4-carboxamide; (B040) N-[(1S,4R)-9-
(dichloromethylene )-1 ,2,3,4-tetrahydro-1 ,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-
methyl-IH-pyrazole-4-carboxamide; (B041) N -[1-(2,4-dichlorophenyl)-l-methoxypropan-2-
yl]-3-( difluoromethyl)-1-methyl-IH-pyrazole-4-carboxamide; (B042) N-[2-chloro-6-
(trifluoromethyl)benzyl]-N -cyclopropyl-3-( difluoromethyl)-5-fluoro-1-methyl-IH -pyrazole-
4-carboxamide; (B043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-
(difluoromethyl)-5-fluoro-1-methyl-IH-pyrazole-4- carboxamide; (B044) N-[5-
chloro-2-( trifluoromethyl)benzyl]-N -cyclopropyl-3-( difluoromethyl)-5-fluoro-1-methyl-IHpyrazole-
4-carboxamide; (B045) N -cyclopropyl-3-( difluoromethyl)-5-fluoro-1-
methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-IH-pyrazole-4-carboxamide; (B046) Ncyclopropyl-
3-( difluoromethyl)-5-flu oro-N -(2-fluoro-6-isopropylbenzyl)-1-methyl-IHpyrazole-
4-carboxamide; (B04 7) N -cyclopropyl-3-( difluoromethyl)-5-flu oro-N -(2-isopropyl-
5-methylbenzyl)-1-methyl-IH-pyrazole-4-carboxamide; (B048) N -cyclopropyl-3-
(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-IH-pyrazole-4-carbothioamide;
(B049) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-IHpyrazole-
4-carboxamide; (B050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-
isopropylbenzyl)-1-methyl-lH-pyrazole-4-carboxamide; (B051) N-cyclopropyl-3-
( difluoromethyl)-N -(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-IH -pyrazole-4-
carboxamide; (B052) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-
1-methyl-IH-pyrazole-4-carboxamide; (B053) N -cyclopropyl-3-( difluoromethyl)-N-(2-ethyl-
5-methylbenzyl)-5-fluoro-1-methyl-IH-pyrazole-4-carboxamide; (B054) N-cyclopropyl-N(
2-cyclopropyl-5-fluorobenzyl )-3-( difluoromethyl)-5-fluoro-1-methyl-lH -pyrazole-4-
carboxamide; (B055) N -cyclopropyl-N -(2-cyclopropyl-5-methylbenzyl)-3-( difluoromethyl)-
5-fluoro-1-methyl-IH -pyrazole-4-carboxamide; (B056) N -cyclopropyl-N -(2-
cyclopropylbenzyl)-3-( difluoromethyl)-5-fluoro-1-methyl-IH -pyrazole-4-carboxamide;
(B057) 2-( difluoromethyl)-N -(1, !-dimethyl-3-propyl-2,3-dihydro-IH -inden-4-
yl)nicotinamide; (B058) pyrapropoyne; (B059) inpyrfluxam; and (B060) isoflucypram,
35 (C) Inhibitors of the respiratory chain at complex III including (COOl) ametoctradin; (C002)
amisulbrom; (C003) azoxystrobin; (C004) coumethoxystrobin; (COOS) coumoxystrobin;
(C006) cyazofamid; (C007) dimoxystrobin; (COOS) enoxastrobin; (C009) famoxadone;
116
5
10
15
wo 2022/009058 PCT/IB2021/055992
(COlO) fenamidone; (COil) flufenoxystrobin; (C012) fluoxastrobin; (C013) kresoxim-methyl;
(C014) metominostrobin; (C015) orysastrobin; (C016) picoxystrobin; (C017) pyraclostrobin;
(C018) pyrametostrobin; (C019) pyraoxystrobin; (C020) trifloxystrobin; (C021) (2E)-2-{2-
[( { [(lE)-1-(3-{ [(E)-1-fluoro-2
phenyl vinyl ]oxy} phenyl)ethylidene ]amino} oxy)methyl ]phenyl} -2-(methoxyimino )-Nmethylacetamide;
(C022) (2E,3Z)-5-{ [1-( 4-chlorophenyl)-lH-pyrazol-3-yl]oxy }-2-
(methoxyimino)-N,3-dimethylpent-3-enamide; (C023) (2R)-2-{2-[(2,5-
dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide; (C024) (2S)-2-{2-
[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide;
(3S,6S,7R,8R)-8-benzyl-3-[ ( { 3-[ (isobutyryloxy)methoxy ]-4-methoxypyridin-2-
yl }carbonyl)amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7 -yl-2-methylpropanoate
(C025)
(Fenpicoxamid); ( C026) 2-{ 2-[ (2,5 -dimethylphenoxy )methyl ]phenyl}-2-methoxy-Nmethylacetamide
(Mandestrobin); (C027) N -(3-ethyl-3,5,5-trimethylcyclohexyl)-3-
formamido-2-hydroxybenzamide; (C028) (2E,3Z)-5-{ [1-( 4-chloro-2-fluorophenyl)-lHpyrazol-
3-yl ]oxy} -2-(methoxyimino )-N ,3-dimethylpent-3-enamide; (C029) methyl { 5-[3-
(2,4-dimethylphenyl)-lH-pyrazol-1-yl]-2-methylbenzyl }carbamate; (C030) 1-(2-{ [1-( 4-
chlorophenyl)pyrazol-3-yl ]oxymethyl}-3-methylphenyl)-1 ,4-dihydro-4-methyl-5H -tetrazol-5-
one (Metyltetraprole); and (C031) florylpicoxamid,
(D) Inhibitors of the mitosis and cell division including (DOOI) carbendazim; (D002)
20 diethofencarb; (D003) ethaboxam; (D004) fluopicolide; (D005) pencycuron; (D006)
thiabendazole; (D007) thiophanate-methyl; (D008) zoxamide; (D009) 3-chloro-4-(2,6-
25
30
35
difluorophenyl)-6-methyl-5-phenylpyridazine; (DO 1 0) 3-chloro-5-( 4-chlorophenyl )-4-(2,6-
difluorophenyl)-6-methylpylidazine; (DOll) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-
(2,4,6-trifluorophenyl)pyridazine; (D012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-
difluorophenyl)-1,3-dimethyl-IH -pyrazol-5-amine; (DO 13) 4-(2-bromo-4-fluorophenyl)-N -(2-
bromo-6-fluorophenyl)-1,3-dimethyl-IH-pyrazol-5-amine; (D014) 4-(2-bromo-4-
fluorophenyl)-N -(2-bromophenyl)-1 ,3-dimethyl-lH -pyrazol-5-amine; (DO 15) 4-(2-bromo-
4-fluorophenyl)-N -(2-chloro-6-fluorophenyl)-1,3-dimethyl-IH -pyrazol-5-amine; (DO 16) 4-(2-
bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-IH-pyrazol-5-amine; (D017) 4-
(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1 ,3-dimethyl-IH-pyrazol-5-amine; (D018) 4-
(2-chloro-4-fluorophenyl)-N -(2,6-difluorophenyl)-1,3-dimethyl-IH -pyrazol-5-amine; (DO 19)
4-(2-chloro-4-fluorophenyl)-N -(2-chloro-6-fluorophenyl )-1 ,3-dimethyl-lH -pyrazol-5-amine;
(D020) 4-(2-chloro-4-fluorophenyl )-N -(2-chlorophenyl )-1,3-dimethyl-1 H -pyrazol-5-amine;
(D021) 4-(2-chloro-4-fluorophenyl)-N -(2-fluorophenyl)-1 ,3-dimethyl-IH -pyrazol-5-amine;
(D022) 4-( 4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine; (D023) N-
(2-bromo-6-fluorophenyl )-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1 H -pyrazol-5-amine;
(D024) N -(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1 ,3-dimethyl-IH -pyrazol-5-amine;
117
5
10
15
wo 2022/009058 PCT/IB2021/055992
and (D025) N -( 4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1 ,3-dimethyl-lHpyrazol-
5-amine,
(E) Compounds capable to have a multisite action including (EOOl) bordeaux mixture; (E002)
captafol; (E003) captan; (E004) chlorothalonil; (E005) copper hydroxide; (E006) copper
naphthenate; (E007) copper oxide; (E008) copper oxychloride; (E009) copper(II) sulfate;
(EOIO) dithianon; (EOll) dodine; (E012) folpet; (E013) mancozeb; (E014) maneb; (E015)
metiram; (E016) metiram zinc; (E017) oxine-copper; (E018) propineb; (E019) sulfur and
sulfur preparations including calcium polysulfide; (E020) thiram; (E021) zineb; (E022) ziram;
and (E023) 6-ethyl-5,7 -dioxo-6,7 -dihydro-5H-pynolo[3',4':5,6] [1 ,4 ]dithiino[2,3-
c] [1 ,2]thiazole-3-carbonitrile,
(F) Compounds capable to induce a host defence including (FOOl) acibenzolar-S-methyl; (F002)
isotianil; (F003) probenazole; and (F004) tiadinil,
(G) Inhibitors of the amino acid and/or protein biosynthesis including (GOOl) cyprodinil; (G002)
kasugamycin; (G003) kasugamycin hydrochloride hydrate; (G004) oxytetracycline; (G005)
pyrimethanil; (G006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline;
(H) Inhibitors of the A TP production including (HOO 1) silthiofam;
(I) Inhibitors of the cell wall synthesis including (1001) benthiavalicarb; (1002) dimethomorph;
(1003) flumorph; (1004) iprovalicarb; (1005) mandipropamid; (1006) pyrimorph; (1007)
valifenalate; (1008) (2E)-3-( 4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-(morpholin-4-
20 yl)prop-2-en-1-one; and (1009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-l-
25
(morpholin-4-yl)prop-2-en-1-one,
(J) Inhibitors of the lipid and membrane synthesis including (JOOl) propamocarb; (J002)
propamocarb hydrochloride; and (J003) tolclofos-methyl,
(K) Inhibitors of the melanin biosynthesis including (KOOl) tricyclazole; (K002) 2,2,2-
trifluoroethyl { 3-methyl-1-[( 4-methylbenzoyl)amino ]butan-2-yl }carbamate;
(L) Inhibitors of the nucleic acid synthesis including (LOOl) benalaxyl; (L002) benalaxyl-M
(kiralaxyl); (L003) metalaxyl; and (L004) metalaxyl-M (mefenoxam),
(M) Inhibitors of the signal transduction including (MOOl) fludioxonil; (M002) iprodione;
(M003) procymidone; (M004) proquinazid; (MOOS) quinoxyfen; and (M006) vinclozolin,
30 (N) Compounds capable to act as an uncoupler including (NOO 1) fluazinam; and (N002)
35
meptyldinocap,
(0) Further compounds including (0001) abscisic acid; (0002) benthiazole; (0003) bethoxazin;
(0004) capsimycin; (0005) carvone; (0006) chinomethionat; (0007) cufraneb; (0008)
cyflufenamid; (0009) cymoxanil; (0010) cyprosulfamide; (0011) flutianil; (0012)
fosetyl-aluminium; (0013) fosetyl-calcium; (0014) fosetyl-sodium; (0015) methyl
isothiocyanate; (0016) metrafenone; (0017) mildiomycin; (0018) natamycin; (0019) nickel
118
5
10
15
20
25
30
35
wo 2022/009058 PCT/IB2021/055992
dimethyldithiocarbamate; (0020) nitrothal-isopropyl; (0021) oxamocarb; (0022)
oxathiapiprolin; (0023) oxyfenthiin; (0024) pentachlorophenol and salts; (0025)
phosphorous acid and its salts; (0026) propamocarb-fosetylate; (0027) pyriofenone
(chlazafenone ); (0028) tebufloquin; (0029) tecloftalam; (0030) tolnifanide; (0031) 1-( 4-{ 4-
[ ( 5R)-5-(2,6-difluorophenyl )-4,5-dihydro-1,2-oxazol-3-y1] -1,3-thiazol-2-yl} pi peri din -1-yl )-2-
[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone; (0032) 1-( 4-{ 4-[(5S)-5-(2,6-
difluorophenyl)-4,5-dihydro-l,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl)-2-[ 5-methyl-3-
(trifluoromethyl)-lH-pyrazol-l-yl]ethanone; (0033) 2-(6-benzylpyridin-2-yl)quinazoline;
(0034) 2,6-dimethyl-1H,5H -[1 ,4 ]dithiino[2,3-c:5 ,6-c']dipyrrole-1 ,3,5 ,7 (2H,6H)-tetrone;
(0035) 2-[3,5-bis(difluoromethyl)-lH-pyrazol-1-yl]-1-[ 4-( 4-{ 5-[2-(prop-2-yn-1-
yloxy)phenyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl)piperidin-1-yl ]ethanone; (0036)
2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[ 4-( 4-{ 5-[2-chloro-6-(prop-2-yn-1-
yloxy)phenyl]-4,5-dihydro-1 ,2-oxazol-3-yl }-1 ,3-thiazol-2-yl)piperidin-1-yl]ethanone; (0037)
2-[3,5-bis(difluoromethyl)-lH-pyrazol-1-yl]-1-[ 4-( 4-{ 5-[2-fluoro-6-(prop-2-yn-1-
yloxy)phenyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl)piperidin-1-yl ]ethanone; (0038)
2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline; (0039) 2-{ (5R)-3-[2-(l{
[3,5-bis( difluoromethyl)-lH-pyrazol-1-yl]acetyl }piperidin-4-yl)-1 ,3-thiazol-4-yl]-4,5-
dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate; (0040) 2-{ (5S)-3-[2-(l-{ [3,5-
bis( difluoromethyl)-1H -pyrazol-1-yl ]acetyl} piperidin-4-yl)-1 ,3-thiazol-4-yl ]-4,5-dihydro-1,2-
oxazol-5-yl}-3-chlorophenylmethanesulfonate; (0041) 2-{2-[(7,8-difluoro-2-methylquinolin-
3-yl)oxy]-6-fluorophenyl}propan-2-ol; (0042) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-
yl)oxy ]phenyl }propan-2-ol; (0043) 2-{ 3-[2-(1-{ [3,5-bis(difluoromethyl)-1H-pyrazol-1-
yl ]acetyl} piperidin-4-yl)-1 ,3-thiazol-4-yl] -4,5-dihydro-1,2-oxazol-5-yl}-3-
ch1orophenylmethanesulfonate; (0044) 2-{ 3-[2-(1-{ [3,5-is( difluoromethyl)-lH-pyrazol-1-
yl ]acetyl} piperidin-4-yl)-1 ,3-thiazol-4-yl] -4,5-dihydro-1,2-oxazol-5-
yl}phenylmethanesulfonate; (0045) 2-phenylphenol and salts; (0046) 3-(4,4,5-trifluoro-3,3-
dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline; (0047) 3-(4,4-difluoro-3,3-dimethyl-3,4-
dihydroisoquinolin -1-yl )quinoline ( Quinofumelin); ( 0048) 4-amino-5-fluoropyrimidin-2-ol
(tautomeric form: 4-amino-5- fluoropyrimidin-2(1H)-one); (0049) 4-oxo-4-[(2-
phenylethyl)amino]butanoic acid; (0050) 5-amino- 1,3,4-thiadiazole-2-thiol; (0051) 5-
ch1oro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide; (0052) 5-fluoro-2-[(4-
fluorobenzyl )oxy ]pyrimidin -4-amine; ( 005 3) 5-flu oro-2-[ ( 4-methylbenzyl )oxy ]pyrimidin -4-
amine; (0054) 9-fluoro-2,2-dimethyl-5-( quinolin-3-yl)-2,3-dihydro-1 ,4-benzoxazepine;
(0055) but-3-yn-1-yl { 6-[( { [(Z)-(l-methyl-1H-tetrazol-5-
yl)(phenyl)methylene]amino }oxy)methyl]pyridin-2-yl}carbamate; (0056) ethyl (2Z)-3-
amino-2- cyano-3-phenylacrylate; (0057) phenazine-1-carboxylic acid; (0058) propyl 3,4,5-
trihydroxybenzoate; (0059) quinolin-8-ol; (0060) quinolin-8-ol sulfate (2:1); (0061) tert-
119
wo 2022/009058 PCT/IB2021/055992
butyl { 6-[( { [(1-methyl-IH-tetrazol-5-yl)(phenyl)methylene]amino }oxy)methyl]pyridin-2-
yl }carbamate; (0062) 5-fluoro-4-imino-3-methyl-1-[( 4-methylphenyl)sulfonyl]-3,4-
dihydropyrimidin-2(1H)-one; (0063) fluoxapiprolin; (0064) pyridachlometyl; (0065)
ipflufenoquin; and (0066) aminopyrifen, and
5 (P) Inhibitors of histone deacetylase including (POOl) N-(1-ethylcyclopropyl)-4-[5-
10
15
20
25
30
35
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (P002) N-(2-isopropylcyclopropyl)-4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (P003) N-(2-methylcyclopropyl)-4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]benzamide;
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]benzamide;
(P004)
(P005)
N-(1-methylcyclopropyl)-4-[5-
N -(2-ethylcyclopropyl)-4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]benzamide; (P006) N -(2,4-difluorophenyl)-4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (P007) 5-(trifluoromethyl)-3-[4-[[3-
(trifluoromethyl)-1 ,2,4triazol-1-yl]methyl]phenyl]-l ,2,4-oxadiazole; (P008) 2-[[ 4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl] -1 ,2,4-triazole-3-carbonitrile; (P009)
ethyl 1-[[ 4-[ 5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl]methyl ]pyrazole-4-carboxylate;
(POlO) N-cyclopropyl-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]pyrazole-4-carboxamide; (POll) N,N -dimethyl-!-[[ 4-[5-(trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide; (P012) N-methyl-1-[[ 4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide; (P013) N,N,dimethyl-
H[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl] -1 ,2,4-triazol-3-
amine; (P014) 3-[ 4-[(5-ethylsulfanyl-1 ,2,4-triazol-1-yl)methyl]phenyl]-5-(trifluoromethyl)-
1 ,2,4-oxadiazole; (POlS) 3-[ 4-(triazolo[ 4,5-b ]pyridin-1-ylmethyl)phenyl]-5-(trifluoromethyl)-
1 ,2,4-oxadiazole; (PO 16) 3-[ 4-( triazolo[ 4,5-b ]pyridin -2-ylmethyl)phenyl] -5-(trifluoromethyl)-
1 ,2,4-oxadiazole; (P017) 3-[ 4-(triazolo[ 4,5-b ]pyridin-3-ylmethyl)phenyl]-5-(trifluoromethyl)-
1,2,4-oxadiazole; (P018) methyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl ]phenyl ]methyl ]pyrazole-4-carboxylate; (PO 19) ethyl 1-[[3-fluoro-4-[5-( trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate; (P020) N,N -diethyl-1-[[ 4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide; (P021) Nmethoxy-
N -methyl-1-[[ 4-[ 5-( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl ]pyrazole-
4-carboxamide; (P022) propyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl]phenyl]methyl]pyrazole-4-carboxylate; (P023) N-methoxy-1-[[ 4-[5-(trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide; (P024) N-ethyl-1-[[ 4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxamide; (P025) 1-[[ 4-
[5-( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl ]methyl ]pyrazole-4-carboxamide; (P026) Nmethoxy-
1-[1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazol-4-
yl]methanimine; (P027) ethyl 1-[1-[ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl ]phenyl ]ethyl ]pyrazole-4-carboxylate; (P028) 1-[[ 4-[5-( trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]pyrrolidin-2-one; (P029) 1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
120
5
10
15
20
25
30
35
wo 2022/009058 PCT/IB2021/055992
yl]phenyl]methyl]piperidin-2-one; (P030) 4-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]morpholin-3-one; (P031) 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-
oxadiazol-3-yl ]phenyl ]methyl ]isoxazolidin-3-one; (P032) 2-[[ 4-[5-( trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one; (P033) 5,5-dimethyl-2-[[4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]isoxazolidin-3-one; (P034) 3,3-
dimethyl-! [ 4-[ 5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl]methyl ]pi peri din -2-one;
(P035) 1-[[2-fluoro-4-[ 5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]pyrrolidin -2-
one; (P036) 1-[[2-fluoro-4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]piperidin-2-one; (P037) 2-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]oxazinan-3-one; (P038) 1-[[3-fluoro-4-[5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]methyl]piperidin-2-one; (P039) 3-[[ 4-[5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]methyl]oxazolidin-2-one; (P040) 1-methyl-3-[[ 4-[5-(trifluoromethyl)-
1,2,4-oxadiazol-3-yl]phenyl]methyl]imidazolidin-2-one; (P041) 1-[[3-fluoro-4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl]-3,3-dimethyl-piperidin-2-one; (P042)
1-[[3-fluoro-4-[ 5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]pyrrolidin -2-one;
(P043) 2-[[3-fluoro-4-[5-( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]-4,4-dimethylisoxazolidin-
3-one; (P044) 2-[[2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl ]phenyl ]methyl ]isoxazolidin-3-one; (P045) 2-[[3-fluoro-4-[ 5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl ]phenyl ]methyl ]isoxazolidin-3-one; (P046) 1-[[3-fluoro-4-[5-(trifluoromethyl)-
1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one; (P047) N-[[4-[5-(trifluoromethyl)-1,2,4-
oxadiazol-3-yl ]phenyl ]methyl ]propanamide; (P048) 2,2-dimethyl-N -[[ 4-[5-( trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl]but-3-ynamide; (P049) N -[[ 4-[5-( trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl ]phenyl ]methyl ]butanamide; (P0 50) 3-methyl-N -[[ 4-[ 5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl ]phenyl ]methyl ]butanamide; (P0 51) 2-methyl-N -[[ 4-[ 5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]methyl]prop-2-enamide; (P052) 2-methyl-N-[[4-[5-(trifluoromethyl)-
1,2,4-oxadiazol-3-yl]phenyl]methyl]butanamide; (P053) 2-methoxy-N-[[4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl]; (P0 54) 3,3,3-trifluoro-N -[[3-fluoro-4-
[5-( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl ]methyl ]propanamide; (P0 55) 3,3,3-trifluoroN-
[[2-fluoro-4-[ 5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]propanamide; (P0 56)
N- [[2,3-difluoro-4-[ 5-( trifluoromethyl )-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl] butanamide;
(P0 57) N -[[2,3-difluoro-4-[ 5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl]-3,3,3-
trifluoro-propanamide; (P058) 2-(difluoromethoxy)-N-[[4-[5-(trifluoromethyl)-1,2,4-
oxadiazol-3-yl]phenyl]methyl]acetamide; (P059) 2-methoxy-2-methyl-N-[[4-[5-
( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]propanamide; (P060) 1-methyl-3-[[ 4-
[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P061) 1-ethyl-1-methyl-3-[[ 4-
[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P062) 1-ethoxy-3-[[ 4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P063) 1-methoxy-1-methyl-3-
121
5
10
15
20
25
30
35
wo 2022/009058 PCT/IB2021/055992
[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]; (P064) 1 ,1-diethyl-3-[[ 4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P065) N-methoxy-N-[[4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]cyclopropanecarboxamide; (P066) Nmethoxy-
N -[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-y1 ]phenyl ]methyl ]pent -4-ynamide;
(P067) N-methoxy-2-methyl-N-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]prop-2-enarnide; (P068) N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-
oxadiazol-3-yl]phenyl]methyl]propanamide; (P069) N-cyclopropyl-3,3,3-trifluoro-N-[[4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]propanamide; (P070) 2,2-difluoro-N(
2-methoxyethyl)-N -[[ 4-[ 5-( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]cyclo
propanecarboxamide; (P071) N -ethyl-2-methyl-N-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]propanamide; (P072) N-[[3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-
3-yl]phenyl]methyl]-N-methoxy-propanamide; (P073) 2-methoxy-N-(2,2,2-trifluoroethyl)-N[[
4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl] acetamide; (P074) N-[[2,3-
difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-N-methoxycyclopropane
carboxamide; (P075) 2-(difluoromethoxy)-N-methyl-N-[[4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide; (P076) N-ethoxy-2-
methoxy-N -[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-y1 ]phenyl ]methyl ]propanamide;
(P077) N-isopropyl-N-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]tetrahydrofuran-2-carboxarnide; (P078) 1-methoxy-3-methyl-1-[[ 4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P079) 3-cyclopropyl-1-methoxy-
1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P080) 3-ethoxy-1-
methoxy-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P081) 3-allyl-
1-methoxy-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P082) 1-
cyclopropyl-3-methoxy-3-methyl-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl]phenyl]methyl]urea; (P083) 3-isopropyl-1-methoxy-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]methyl]urea; (P084) 1-methoxy-3-prop-2-ynyl-1-[[ 4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P085) 1-[[3-fluoro-4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]methyl]-1-methoxy-3-methyl-urea; (P086) 3-
(cyclopropylmethyl)-1-methyl-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl ]phenyl ]methyl ]urea; (P087) 1-ethyl-3-(2,2,2-trifluoroethyl)-1-[[ 4-[5-( trifluoromethyl)-
1 ,2,4-oxadiazol-3- yl]phenyl]methyl]urea; (P088) 1 ,3-dimethoxy-1-[[ 4-[5-(trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl]phenyl]methyl]urea; (P089) 3-ethyl-1-methoxy-1-[[ 4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl]urea; (P090) N -methyl-4-[5-
( trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]benzarnide; (P091) N -[ (E)-methoxyirninomethyl] -4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl ]benzarnide; (P092) N -[ (Z)-methoxyirninomethyl] -4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]benzarnide; (P093) N-[ 4-[5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]cyclopropanecarboxamide; (P094) N-(2-fluorophenyl)-4-[5-
122
5
10
15
20
wo 2022/009058 PCT/IB2021/055992
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (P095) 2,2-difluoro-N-methyl-2-[4-[5-
(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl]acetamide; (P096) N -allyl-N-[[ 4-[5-
(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide; (P097) N-[(E)-N-methoxyC-
methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (P098) N[(
Z)-N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-
yl]benzamide; (PIOO) N -allyl-N-[[ 4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-
yl ]phenyl ]methyl ]propanamide; (PI 01) 4,4-dimethyl-1-[[ 4-[5-(trifluoromethyl)-1 ,2,4-
oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one; (P102) N-methyl-4-[5-(trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl]benzenecarbothioamide and (P103) 5-methyl-1-[[ 4-[5-(trifluoromethyl)-
1 ,2,4-oxadiazol-3-yl ]phenyl ]methyl ]pyrrolidin-2-one.
5. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
insecticidally active compound (II) selected from
(11-2) GABA-gated chloride channel blockers;
(II-3) Sodium channel modulators (Pyrethroids/Pyrethrins);
(11-4) Nicotinic acetylcholine receptor (nAChR) competitive modulators;
(11-5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators- Site I;
(11-6) Glutamate-gated chloride channel (GluCl) allosteric modulators;
(11-7) Juvenile hormone mimics;
(11-9) Chordotonal organ TRPV channel modulators;
(II-11) Microbial disruptors of insect midgut membranes;
(11-13) Uncouplers of oxidative phosphorylation via disruption of the proton gradient;
(11-22) Voltage-dependent sodium channel blockers;
(11-28) GABA-gated chloride channel allosteric modulators; and
(11-31) Insecticidal active compounds of unknown or uncertain mode of action.
25 6. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
30
35
fungicidally active compound (III) selected from
(A) Inhibitors of the ergosterol synthesis;
(B) Inhibitors of the respiratory chain at complex I or II;
(C) Inhibitors of the respiratory chain at complex III;
(D) Inhibitors of the mitosis and cell division;
(E) Compounds capable to have a multisite action;
(L) Inhibitors of the nucleic acid synthesis;
(M) Inhibitors of the signal transduction;
(N) Compounds capable to act as an uncoupler; and
(P) Inhibitors of histone deacetylase.
123
wo 2022/009058 PCT/IB2021/055992
7. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
fungicidally active compound (III) selected from (A001) cyproconazole, (A002) difenoconazole,
(A003) epoxiconazole, (A006) fenpropimorph, (A009) flutriafol, (A013) metconazole, (A017)
propiconazole, (A018) prothioconazole, (A021) tebuconazole, (A022) tetraconazol, (A081)
5 mefentrifluconazole, (B001) benzovindiflupyr, (B002) bixafen, (BOOS) fluopyram, (B007)
fluxapyroxad, (B019) pydiflumetofen, (B30) fluindapyr, (BOS9) inpyrfluxam, (C003)
azoxystrobin, (C012) fluoxastrobin (C014) metominostrobin, (C017) pyraclostrobin, (C016)
picoxystrobin, (C020) trifloxystrobin, (C02S) (3S,6S, 7R,8R)-8-benzyl-3-[ ( { 3-
[ (isobutyryloxy)methoxy] -4-methoxypyridin -2-yl} carbonyl)amino] -6-methyl-4,9-dioxo-1 ,S-
10 dioxonan-7 -yl-2-methylpropanoate (Fenpicoxamid), (C030) 1-(2-{ [1-( 4-chlorophenyl)pyrazol-3-
yl ]oxymethyl}-3-methylphenyl)-1 ,4-dihydro-4-methyl-SH -tetrazol-S-one (Metyltetraprole ),
(D001) carbendazim, (D007) thiophanate-methyl, (E004) chlorothalonil, (EOIO) dithianon, (E013)
mancozeb, (E020) thiram, (F002) Isotianil, (F003) Probenazole, (L003) metalaxyl, (M001)
fludioxonil, (N001) fluazinam, (0022) Oxathiapiprolin, (0043) 2-{3-[2-(l-{[3,S-
15 bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl }piperidin-4-yl)-1,3-thiazol-4-yl]-4,S-dihydro-1 ,2-
oxazol-S-yl}-3-chlorophenyl methanesulfonate (fluoxapiprolin), (0046) 3-(4,4,S-trifluoro-3,3-
dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (0047) 3-( 4,4-difluoro-3,3-dimethyl-3,4-
dihydroisoquinolin-1-yl)quinoline (Quinofumelin), (006S) ipflufenoquin and (P094) N -(2-
fluorophenyl)-4-[S-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide.
20 8. The pesticidal mixture according to claim 7, wherein said component (2) is at least one fungicidally
25
active compound (III) selected from (C003) Azoxystrobin, (C017) Pyraclostrobin, (L003)
Metalaxyl, (D007) Thiophanate-methyl, (B007) Fluxapyroxad, (M001) Fludioxonil, (F003)
Probenazole, (F002) Isotianil and (BOOS) Fluopyram.
9. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
insecticidally active compound (II) selected from Abamectin (Z166), Acephate (Z027),
acetamiprid (Z148). Afidopyropen (Z190), alpha -cypermethrin (Zl14), Bifenthrin (Z103),
Broflanilide (Z273), Benzpyrimoxan (Z28S), buprofezin (Z221), Chlorfenapyr (Z203),
Clothianidin (Z149), cyhalothrin (ZllO), Cypermethrin (Z113), Diafenthiuron (Z197),
Dimpropyridaz (Z3170, dinotefuran (Z1SO), Emamectin benzoate (Z167), flonicamid (Z272),
30 Fluxametamide (Z274), Flupyrimin (Z163), Fipronil (Z09S), Fluhexafon (Z293), Flometoquin
(Z292), Imidacloprid (Z1S1), Indoxacarb (Z240), Isocycloseram (Z27S), Metaflumizone (Z241),
Oxazosulfyl (Z243), Pyridalyl (Z299), Pymetrozine (Z188), Pyriproxyfen (Zl74), Spirodiclofen
(Z244), Spiropidion (Z246), Spinetoram (Z164), Spinosad (Z16S), spirotetramat (Z247),
Thiamethoxam (Z1S4), Teflubenzuron (Z219), thiacloprid (Z1S3),Triflumezopyrim (Z161) and
35 Tyclopyrazoflor (Z318) ..
124
wo 2022/009058 PCT/IB2021/055992
10. The pesticidal mixture according to claim 1 or 2, wherein said component (2) is at least one
insecticidally active biological compound (II) selected from from the class of (II -llA) Bacillus
thuringiensis (Z195) and the insecticidal proteins they produce including bacillus
thuringiensis or bacillus sphaericus and the insecticdal proteins they produce such as bacillus
5 thuringiensis subsp. israelensis, bacillus sphaericus, bacillus thuringiensis subsp. aizawai, bacillus
thuringiensis subsp. kurstaki and bacillus thuringiensis subsp. tenebrionis, or the B.t crop proteins:
Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb and
Cry34/35Ab1,
11. The pesticidal mixture according to claim 1 to 10, wherein said mixture further comprises an
10 agriculturally acceptable auxiliaries, solvents, carriers, surfactants or extenders.
12. The pesticidal mixture according to claim 1 to 10, wherein component (1) and said component (2)
is in a weight ratio of from 1000: 1 to 1:1000.
13. The pesticidal mixture according to claim 1 to 10, wherein component (1) and said component (2)
is in a weight ratio of from 100: 1 to 1: 100.
15 14. A method for controlling insects, acarids, nematodes, phytopathogenic fungi compnsmg
contacting an insect, acarid, nematode, phytopathogenic fungi or their food supply, habitat,
breeding grounds or their locus with a pesticidally effective amount of a mixture according to
any of the claims 1 to 10.
15. A method of protecting plants from attack or infestation by insects, acarids, nematodes or
20 phytopathogenic fungi comprising contacting the plant, or the soil or water in which the plant is
growing, with a pesticidally effective amount of a mixture according to any of the claims 1 to 10.
16. A seed, comprising the pesticidal mixture according to any of claims 1 to 10 in an amount from
0.1 g to 10 kg per 100 kg of seeds.
17. A method for the protection of plant propagation material compnsmg contacting the plant
25 propagation material with a mixture according to any of the claims 1 to 10 in pesticidally
effective amounts.
18. Use of pesticidal mixture according to any of the claims 1 to 10 for controlling or preventing
agricultural crops and/or horticultural crops against pests like insects from the order of the
lepidopterans (Lepidoptera), beetles (Coleoptera), flies and mosquitoes (Diptera ), thrips
30 (Thysanoptera), termites (lsoptera), bugs, aphids, leafhoppers, whiteflies, scale insects, cicadas
(Hemiptera), ants, bees, wasps, sawflies (Hymenoptera), crickets, grasshoppers, locusts
(Orthoptera), and also Arachnoidea, such as arachnids (Acarina).
125
wo 2022/009058 PCT/IB2021/055992
19. Use of pesticidal mixture according to any of the claims 1 to 10 for controlling or preventing
crops and/or horticultural crops against diseases caused by insects, acarids, nematodes or
phytopathogenic fungi.
20. Use of pesticidal mixture according of the claims 1 to 10 for treating seed, seed of transgenic
5 plants and transgenic plants.